Literature DB >> 17453636

The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40): evidence for a method of imputing missing data.

Crispin Jenkinson1, Robert Harris, Ray Fitzpatrick.   

Abstract

The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) is the most widely validated measure of health status for use with patients diagnosed with motor neuron disease/amyotrophic lateral sclerosis (MND/ALS). The questionnaire was designed to be used in studies evaluating treatment regimes where missing data may cause problems with data analyses. The purpose of this paper is to evaluate an algorithm for the imputation of missing dimension scores on the ALSAQ-40. We used a postal survey of patients diagnosed with MND/ALS. One thousand, nine hundred and seventy-nine patients were surveyed and 1093 (55.2%) questionnaires returned. Of these, complete ALSAQ-40 data was available in 854 (85.8%) cases. Data were deleted from this complete dataset, and in a randomly selected subset of 100 cases, and then imputed using the Expectation Maximization (EM) algorithm: results were then compared to the dataset prior to data deletion. Descriptive statistics, mean scores and spread of scores were almost identical between original and imputed datasets. Furthermore, the two datasets were highly correlated (intra-class correlation coefficient = 0.95 or greater), and mean differences were small (+/-1.00). We concluded that EM imputation for the ALSAQ-40 provides data that closely mirrors the original when this has been deliberately removed. Consequently, EM is likely to be appropriate for studies using the ALSAQ-40 that contain missing data points.

Entities:  

Mesh:

Year:  2007        PMID: 17453636     DOI: 10.1080/17482960600989343

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  3 in total

1.  Searching for success: Development of a combined patient-reported-outcome ("PRO") criterion for operationalizing success in multi-modal pain therapy.

Authors:  Carolin Donath; Lisa Dorscht; Elmar Graessel; Reinhard Sittl; Christoph Schoen
Journal:  BMC Health Serv Res       Date:  2015-07-17       Impact factor: 2.655

2.  Validation of a core patient-reported-outcome measure set for operationalizing success in multimodal pain therapy: useful for depicting long-term success?

Authors:  Carolin Donath; Christa Geiß; Christoph Schön
Journal:  BMC Health Serv Res       Date:  2018-02-17       Impact factor: 2.655

3.  The Fitting Optimization Path Analysis on Scale Missing Data: Based on the 507 Patients of Poststroke Depression Measured by SDS.

Authors:  Xiaoying Lv; Ruonan Zhao; Tongsheng Su; Liyun He; Rui Song; Qizhen Wang; Xueyun Yu; Yanbo Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-13       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.